A Study of PHN-012 in Patients With Advanced Solid Tumors
Pheon Therapeutics
Pheon Therapeutics
Astellas Pharma Inc
Iambic Therapeutics, Inc
Amgen
Revolution Medicines, Inc.
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
DeuterOncology
Alterome Therapeutics, Inc.
Pfizer
Pfizer
Aptamer Sciences, Inc.
AbbVie
GlaxoSmithKline
Rondo Therapeutics
Conjupro Biotherapeutics, Inc.
RasCal Therapeutics, Inc.
Dragonfly Therapeutics
Merck Sharp & Dohme LLC
Daiichi Sankyo
Nuvectis Pharma, Inc.
ViroMissile, Inc.
Replimune Inc.
Pfizer
AstraZeneca
Tizona Therapeutics, Inc
National Institutes of Health Clinical Center (CC)
Werewolf Therapeutics, Inc.
Pheon Therapeutics
Boehringer Ingelheim
Tesaro, Inc.
AbbVie
AgonOx, Inc.
Novartis
Calico Life Sciences LLC
Sairopa B.V.
Bristol-Myers Squibb
AbbVie
Degron Therapeutics Co.
Tesaro, Inc.
AstraZeneca
AstraZeneca
Amgen
AstraZeneca
University of California, San Diego
Boehringer Ingelheim
Coherus Oncology, Inc.
Stanford University
Tesaro, Inc.
Pfizer